Recludix Pharma
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$248M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Recludix Pharma operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in January 2026.
Recludix Pharma is a biotechnology company that develops innovative small-molecule inhibitors for challenging protein targets to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recludix Pharma Comparables
Compare Recludix Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BridgeBio Pharma, Inc. | 81% | |
| Erasca | 80% | |
| Revolution Medicines | 80% |
For institutional investors. Book with your work email.
Recludix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Strategic | Jul 20, 2023 | ||||
| Series A | Nov 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Recludix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A |
| Westlake Village BioPartners | Series A, Series B |
| New Enterprise Associates | Series A, Series B |
| Alexandria Venture Investments | Series B |
| Access Biotechnology | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 101% MoM, reaching 7.4K.
- Jul 28, 2026
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 22, 2026
Recludix Pharma, Inc. is advancing a potential first-in-class BTK SH2 domain inhibitor for B cell or mast cell-driven I&I diseases, as well as additional discovery programs, as of Sep 17th '26 in California.
- attends_eventSep 17, 2026
Recludix Pharma, Inc. is scheduled to present an overview of the company at the virtual Stifel 2026 Virtual Immunology and Inflammation Forum on Sep 24th '26.
For institutional investors. Book with your work email.
Recludix Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Recludix Pharma's valuation, stock price, and market status.
Is Recludix Pharma a public or private company?
Recludix Pharma is a private company.
What is the current stock price of Recludix Pharma?
Recludix Pharma is a private company, so its shares have no public market price. Caplight tracks Recludix Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Recludix Pharma worth (valuation)?
Valuation information for Recludix Pharma is not publicly available.
Can I buy Recludix Pharma stock?
Recludix Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Recludix Pharma's last funding round?
Recludix Pharma's most recent funding round was Series B on January 12, 2026.
Who are the main investors in Recludix Pharma?
Key investors in Recludix Pharma include Access Industries, Westlake Village BioPartners, New Enterprise Associates, Alexandria Venture Investments, Access Biotechnology.
Will Recludix Pharma IPO soon?
No public IPO plans have been announced for Recludix Pharma.
How can I track Recludix Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Recludix Pharma's shares on secondary markets.